Human 3 with Brom and Sam10 Jun 2025

Brain implants without a hole in your skull - Wes Jones of Vonova

Wes Jones is the CEO of Vonova, a brain computer interface company that (unlike Neuralink) is enabling access to the brain without drilling a hole in your skull.

Wes joins Brom Rector and Sam Tabone to discuss:

(1:25) - how Wes got into neuro, background as a catheter engineer

(6:30) - how Wes’s parachute malfunction and resulting paralysis made him focused on the brain

(10:30) - how Wes met his cofounder

(14:00) - Wes demonstrating how his device treats chronic subdural hematoma

(18:00) - ancient Peruvian history of brain surgery + the problem of the skull

(22:30) - how does Vonova’s device actually work

(26:00) - Wes’s encounter with Lawrence Livermore National Labs

(28:00) - how Vonova is different than Neuralink

(35:00) - how Vonova could treat chronic pain

(38:00) - could Vonova’s device be used for Neurodegenerative disease

(41:00) - how long does Vonova's device stay implanted?

(43:00) - Wes’s fundraising journey - the challenges of medtech

(47:30) - why wes is excited about drug device combos and a primer on the blood brain barrier + how Vonova could be used for drug delivery

(53:00) - could Vonova’s device be used for brain stimulation

(56:20) - how Vonova’s device could help “solve” the brain + digital twins

(1:00:00) - Wes’s experience as a CEO + his first employee living on his couch for a year

(1:05:00) - does Wes think you need an MBA to start a company (hot take)

(1:08:00) - San Diego

https://www.vonova.io/

Denne episoden er hentet fra en åpen RSS-feed og er ikke publisert av Podme. Den kan derfor inneholde annonser.

Episoder(33)

Dave Messina - YC founder turned investor talks TechBio

Ever wondered what Pioneer Fund’s Future of Health Fund is excited about? Want to know how to impress Dave Messina? Are you curious about how different funds communicate and interact?Give a listen to ...

6 Jul 1h 16min

$HIMS Q2 Results - our take as healthcare venture capitalists

Brom Rector and Sam Tabone from XEIA Venture Partners - a VC firm that invests in the future of human health, wellbeing and performance - discuss $HIMS Q2 results and the HIMS business more broadly. W...

5 Aug 20251h 24min

Investing in Psychedelic BioTech [August 2025 webinar replay]

Watch the video recording on YouTube: https://youtu.be/BM6x59oMnKg?si=qF0xDvgUMvU60ctP2025 has been the start of a bull period for psychedelic medicine.Psychedelic Biotechs like GH Research, Compass ...

30 Jul 202558min

Compass and ATAI latest news + are Psychedelics BACK in 2025?!

The past few years have been rough for psychedelic and shroom stocks, but recent news from ATAI (and Recognify), Compass Pathways and GH Research + positive regulatory tailwinds from RFK and MAHA make...

29 Jul 202516min

Bryan Johnson's Neuralink competitor - with Kernel CEO Ryan Field

Ryan Field is the CEO of Kernel, a brain-computer interface company founded by Bryan Johnson. Kernel is a cutting edge, non-invasive BCI that uses fNIRS to image the brain. Imagine if getting an MRI w...

22 Jul 20251h 33min

How to start a VC fund

I interviewed Michael Huseby to learn about his life story and his new book: Fundamentals: Your Friendly Guide to Investment Funds and SyndicationsThis is a great listen for anyone interested in start...

15 Jul 20251h 20min

Beyond Neuralink - Investing in Brain Computer Interfaces [webinar replay]

Replay of our webinar on investing in brain computer interfaces. Join our upcoming July 30th event on investing in psychedelic biotech: psybio.org

12 Jul 20251h 9min

Designing Novel Brain Drugs with Xylo Bio

Xylo is a biotech startup that is using computational methods to design novel brain drugs to treat mental health disorders and neurodegeneration. Many of their drug candidates are inspired by naturall...

8 Jul 20251h